Analysts Offer Insights on Financial Companies: SelectQuote (SLQT) and Nasdaq (NDAQ)
Analysts at Noble Financial and UBS reiterated bullish views on SelectQuote (SLQT) and Nasdaq (NDAQ). Noble’s Michael Kupinski kept a Buy on SLQT with a $5.00 target versus a $0.69 close. UBS’s Alex Kramm kept a Buy on NDAQ with a $120 target versus a $90.42 close. TipRanks consensus targets were also cited.
How this was made
The 30-second read
Why it matters
For traders, the only fresh information is the specific reiterated Buy ratings and target levels; there is no new earnings, guidance, regulatory action, or transaction detail.
Market read
Bullish analyst target updates may influence short-term sentiment, but the article lacks new fundamental catalysts.
What to watch
The article is promotional/aggregator-style and does not provide the underlying thesis, valuation assumptions, or any new operational metrics that would justify the target changes.
Background
The piece summarizes two separate analyst notes on SelectQuote (SLQT) and Nasdaq (NDAQ), including Buy ratings and stated price targets, plus consensus context.
Ticker impact
Article says analyst Michael Kupinski reiterated a Buy on SelectQuote with a $5.00 price target and cites prior close at $0.69.
Mild positive bias for SLQT as traders react to the fresh $5.00 target versus the stated $4.00 consensus.
The newest concrete fact is the reiterated Buy and specific $5.00 target; however, the article provides no new company-specific operational or financial datapoint beyond analyst framing.
Article reports UBS analyst Alex Kramm maintained a Buy on Nasdaq with a $120.00 price target and notes a prior close of $90.42.
Slight positive drift for NDAQ as the $120 target and mention of a recent upgrade can attract incremental dip-buying.
The article’s actionable element is the stated $120.00 target and Buy rating; it does not include new fundamentals, only analyst commentary and consensus context.
Market effects
Reinforces generally constructive sentiment toward financial-services equities via analyst coverage, but no sector-wide new data is provided.
No specific regional macro or cross-market catalyst is disclosed.
No global event or cross-border transaction is mentioned.
Counterpoint
Price targets can lag or fail to materialize; without new earnings, guidance, or measurable business updates, the market may discount the reiterations quickly.
Key entities
- companySelectQuote
Receives a reiterated Buy rating and a $5.00 price target in the article.
- companyNasdaq
Receives a maintained Buy rating and a $120.00 price target in the article.
- analystMichael Kupinski
Noble Financial analyst cited as reiterating Buy on SLQT with a $5.00 target.
- analystAlex Kramm
UBS analyst cited as maintaining Buy on NDAQ with a $120.00 target.
